🇺🇸 FDA
Patent

US 11325973

Modulation of stimulatory and non-stimulatory myeloid cells

granted A61KA61K2039/505A61K2239/49

Quick answer

US patent 11325973 (Modulation of stimulatory and non-stimulatory myeloid cells) held by The Regents of the University of California expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61K2239/49, A61K40/11, A61K40/42